HKG epiTherapeutics Launches Next-Generation Sequencing-Based epiAge Test to Discover Your Biological Age

HKG epiTherapeutics is on a mission to improve healthcare and well-being for people worldwide 

Hong Kong (Sept. 30, 2019) – HKG epiTherapeutics, a Hong Kong-based startup, has announced today the launch of their first product “epiAge”. Through a simple saliva test, customers are provided with a data set which shows them their biological age. EpiA uses a cutting-edge method known as DNA methylation to reveal information about a person’s true age and health condition, allowing the user to identify the quality and span of their life, encouraging and enabling them to make positive lifestyle changes. 

Starting today, customers can purchase the test on our website and download the app all around the world. Through the EpiAge App customers can retrieve the test report, learn about the science behind epigenetics as well as study health related topics. Based on their specific results and lifestyle, customers can identify how to positively impact their overall health and well-being. 

Founded in 2016 by Prof. Moshe Szyf, holding a Ph.D from Hebrew University, a postdoctoral fellowship in Genetics at Harvard Medical School, a Professorship at McGill University and a Chair in Pharmacology at GlaxoSmithKline, Dr. Szyf is a “pioneer powerhouse” in the rapidly emerging field of epigenetics. The company’s focus lies in the prevention and early detection of diseases such as cancer and chronic diseases in order to positively impact the healthcare, well-being and quality of life for large populations of people worldwide. 

“Our purpose is to take the science of epigenetics and make it useful for everyone. If the science of epigenetics can detect diseases early, why wouldn’t we share it?” – Prof. Moshe Szyf. 

About HKG epiTherapeutics HKG epiTherapeutics Limited (HKG) was established in 2016 by Prof. Moshe Szyf. It is a Research and Development company that develops novel proprietary tests based on DNA methylation and next generation sequencing technology for early detection of diseases such as cancer (including liver cancer, lung cancer, prostate cancer, breast cancer and colorectal cancer, etc.) and aging to adult population who have keen concern about their well being. 

About WHub WHub (whub.io) is Hong Kong’s largest startup community platform (over 22,000 members), community builder and power connector. It showcases startups to accelerate their business through making meaningful connections to the resources they need and fosters the growth of the entire ecosystem. 

If you would like more information about this topic, please call Moshe Szyf at (+852)23548297, or email moshe.szyf@epimedtech.com